These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 921765)
1. Effect of lipophilic character on the biological activity of synthetic angiotensin peptides. Nouailhetas VL; Nakaie CR; Juliano L; Paiva AC Biochem J; 1977 Sep; 165(3):547-51. PubMed ID: 921765 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist. Paiva AC; Nouailhetas VL; Paiva TB J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965 [TBL] [Abstract][Full Text] [Related]
3. 1,8-disubstituted analogues of (Ile5) and (Val5)angiotensin II: difference in potency and specificity of angiotensin II-antagonistic activity. Schoelkens BA; Wissmann H; Lindner E; Geiger R Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):825-38. PubMed ID: 955577 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of biologically active retroenantiomers of angiotensin peptides. Goissis G; Nouaihetas VL; Paiva AC J Med Chem; 1976 Nov; 19(11):1287-90. PubMed ID: 1003405 [TBL] [Abstract][Full Text] [Related]
5. Steroidogenic and pressor activity of angiotensin analogues in the rat. Khairallah PA; Khosla MC; Bumpus FM; Tait JF; Tait SA Clin Sci Mol Med Suppl; 1978 Dec; 4():175s-177s. PubMed ID: 282047 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of angiotensin II antagonists containing sarcosine in position 7. Moore GJ; Oudeman EM; Ko D; Nystrom DM J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564 [TBL] [Abstract][Full Text] [Related]
7. Tachyphylaxis and angiotensin receptors. Paiva TB; Aboulafia J; Nouailhetas VL; Paiva AC Gen Pharmacol; 1976 Aug; 7(2-3):185-8. PubMed ID: 185119 [TBL] [Abstract][Full Text] [Related]
8. Effects of paired analogs of angiotensin II and angiotensin III on rat smooth muscle. Moore GJ; Ko EM Pharmacology; 1980; 20(1):36-41. PubMed ID: 7375500 [TBL] [Abstract][Full Text] [Related]
9. Effect of tyrosine ionization upon biological activities of angiotensin II and two new peptide analogues. Nakaie CR; Oshiro ME; Goissis G; Paiva AC Biochim Biophys Acta; 1977 Nov; 495(1):151-8. PubMed ID: 20979 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and specific pressor activity of [1-aspartic acid,5-valine,9-serine]angiotensin I ("fowl angiotensin I"). Hayashi Y; Nakajima T; Watanabe TX; Sokabe H; Khosla MC; Bumpus FM J Med Chem; 1977 Feb; 20(2):315-6. PubMed ID: 836506 [TBL] [Abstract][Full Text] [Related]
11. Requirements for angiotensin tachyphylaxis in smooth muscles. Paiva TB; Miyamoto ME; Juliano L; Paiva AC J Pharmacol Exp Ther; 1977 Aug; 202(2):294-300. PubMed ID: 886468 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-like and antagonistic activities of N-terminal modified (8-leucine)angiotensin II peptides. Paiva TB; Goissis G; Juliano L; Miyamoto ME; Paiva AC J Med Chem; 1974 Feb; 17(2):239-41. PubMed ID: 4358432 [No Abstract] [Full Text] [Related]
13. Role of the two N-terminal residues of angiotensin II in the production of tachyphylaxis. Miasiro N; Oshiro ME; Paiva TB; Paiva AC Eur J Pharmacol; 1983 Mar; 87(4):397-406. PubMed ID: 6852096 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II analogs. 11. Further studies on des-aspartyl-angiotensin II. Jorgensen EC; Kiraly-Olah IC; Lee TC; Windridge GC J Med Chem; 1974 Mar; 17(3):323-6. PubMed ID: 4359545 [No Abstract] [Full Text] [Related]
15. Synthesis of [1-sarcosine, 8-O-methylserine]angiotensin II and 1-substituted analogues of [8-threonine]angiotensin II as antagonists of angiotensin II. Khosla MC; Hall MM; Munoz-RamÃrez H; Khairallah PA; Bumpus FM J Med Chem; 1977 Feb; 20(2):253-6. PubMed ID: 836496 [TBL] [Abstract][Full Text] [Related]
16. Alkylating analogs of peptide hormones. 2. Synthesis and properties of p-(N,N-bis(2-chloroethyl)amino)phenylbutyryl derivatives of angiotensin II. Paiva TB; Paiva AC; Freer RJ; Stewart JM J Med Chem; 1972 Jan; 15(1):6-8. PubMed ID: 4331919 [No Abstract] [Full Text] [Related]
17. Comparative pharmacology of new specific angiotensin antagonists. Schoelkens BA Clin Sci Mol Med Suppl; 1975 Jun; 2():19s-21s. PubMed ID: 1077769 [TBL] [Abstract][Full Text] [Related]
18. [Synthesis and analysis of cyclic analogs of angiotensin]. Antsans IuE; Bisenietse DA; Vosekalna IA; Myshliakova NV; Chipens GI Bioorg Khim; 1990 Mar; 16(3):358-69. PubMed ID: 2357239 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological activity of angiotensin-II modified by tyrosine sulfation. Hagiwara M; Ohuchi E; Hongo K; Oki M; Wada K; Morikawa T; Kobashi K Jpn J Pharmacol; 1990 Mar; 52(3):493-5. PubMed ID: 2332941 [TBL] [Abstract][Full Text] [Related]
20. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II. Khosla MC; Hall MM; Smeby RR; Bumpus FM J Med Chem; 1974 Nov; 17(11):1156-60. PubMed ID: 4369767 [No Abstract] [Full Text] [Related] [Next] [New Search]